PharmaVOICE Features Advarra CEO in “New Era of Clinical Trials” Cover Story
PharmaVOICE recently featured Gadi Saarony, CEO at Advarra, in its cover article “A New Era of Clinical Trials” discussing how the research industry’s response to the COVID-19 pandemic “will set the course for drug development for years to come.”
Research organizations like Advarra have taken the current challenges as opportunities “to create positive and sustainable changes” that can transform and improve the clinical trial ecosystem. Saarony joined leaders from across the industry in discussing ways their organizations have responded to the crisis and the lasting impact the pandemic will have on clinical operations and R&D.
“Our review committees continue to see growth in gene therapy research, and our consulting practice is staffing more hospital and academic IRBs and CTOs than ever before,” Saarony stated. “From a technology perspective our products have enabled remote study management and monitoring, and our centralized services for calendar build and coverage analysis have enabled research to keep moving forward despite restrictions and limited resources at sites.”
“Most importantly, the challenges and disruptions of the last few months have reminded all of us that we are connected, and this has reinforced our resolve that as a clinical research community we truly are ‘altogether better,’” said Saarony.
PharmaVOICE is a publisher for life sciences executives and other healthcare service-related professionals and acts as a forum allowing business leaders to engage in a candid dialogue on the challenges and trends impacting the industry.
Advarra is committed to supporting the research community throughout the current crisis, putting policies and processes in place to keep operations functioning as normal. For more on the research impact of COVID-19 and ways Advarra can help sponsors, CROs, sites, and institutions restart research, visit Advarra’s Coronavirus Guidance webpage.